Pain News and Research

Latest Pain News and Research

ARIAD Pharmaceuticals' Iclusig gets EC marketing authorization for CML and Ph+ ALL treatment

ARIAD Pharmaceuticals, Inc. today announced that the European Commission has granted a marketing authorization for Iclusig (ponatinib) as an orphan medicinal product for two indications.

2 Jul 2013

State highlights: Calif. bill to fine firms with workers on Medi-Cal fails; Pa. eyes disallowing apologies used against doctors in court-proceedings

A California proposal to fine large companies that have workers on Medi-Cal came up short in an initial vote in the Assembly amid strong business opposition. The proposed fines could reach about $5,000 per full-time employee who receives Medi-Cal, the state Medicaid program for the poor. The bill, AB 880, garnered 46 votes in the 80-member chamber Thursday, short of the 54 votes, or two-thirds majority, needed. The measure could come up for reconsideration as early as next week (Terhune, 6/27).

2 Jul 2013

Research roundup: 'Welcome-mat' effect of Medicaid expansion; Setting up shops; California's transition to Medicaid managed care

The number of people eligible for Medicaid who remain uninsured varies from state to state, according to the authors. But the federal health law is likely to increase the rate of enrollment for this group. The potential impact of this increase in Medicaid enrollment, also known as the 'welcome-mat' effect, is unclear.

2 Jul 2013

Osteoarthritis associated genes: an interview with Professor Jonathan Tobias, University of Bristol

Joints are lined by articular cartilage, loss of which is one of the hallmarks of osteoarthritis. Articular cartilage is made up of a number of proteins, such as type II collagen. In rare forms of osteoarthritis, one of these structural proteins is defective as a result of a genetic mutation.

2 Jul 2013

Lawmakers gird for new abortion fight as Texas special session convenes

Texas lawmakers resume debate on proposed abortion legislation as the state legislature opens a special session Monday. Republicans say they will quickly pass new abortion restrictions despite opponents' efforts. Meanwhile, the Congressional Budget Office projected that a House bill that would ban abortions after 20 weeks would increase Medicaid costs by as much as $400 million.

2 Jul 2013

Study shows that PCCs can reverse blood thinning effects of XARELTO in healthy subjects

Janssen Research & Development, LLC announced today results of an open label, single-center, parallel group study showing that a type of medication called prothrombin complex concentrates can reverse the blood thinning effects of XARELTO (rivaroxaban) in healthy subjects.

2 Jul 2013

Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stage breast cancer

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application for the use of a Perjeta (pertuzumab) regimen before surgery (neoadjuvant treatment) in people with HER2-positive early stage breast cancer.

2 Jul 2013

Tel-Aviv research shows physicians delay diagnosis of cervical spondylotic myelopathy

Researchers from The Tel-Aviv Medical Center found delays in diagnosis of cervical spondylotic myelopathy (CSM) averaging 2 years in 42 patients who eventually underwent surgery. This is an important finding, because previous studies have shown that early diagnosis and treatment of CSM lead to better outcomes.

2 Jul 2013

DNA fragments in blood may help doctors to quickly identify coronary artery disease

DNA fragments in your blood may someday help doctors quickly learn if chest pain means you have narrowed heart arteries, according to a new study published in the American Heart Association journal Arteriosclerosis, Thrombosis, and Vascular Biology.

2 Jul 2013

First Edition: July 1, 2013

Today's headlines include a variety of weekend news reports, including coverage of the Obama administration's final contraceptive coverage rule as well as a range of other stories on health law implementation issues.

1 Jul 2013

Pathway Genomics collaborates with Singapore-based company, Parkway Laboratory Services

Pathway Genomics Corporation, a San Diego-based clinical laboratory that offers genetic testing services internationally, has partnered with Parkway Laboratory Services Ltd, an ancillary service of Parkway Pantai Limited, the largest private healthcare provider in Singapore, and one of the largest private healthcare providers in Asia.

1 Jul 2013

Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets

Bayer HealthCare and Onyx Pharmaceuticals today announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration and an application for marketing authorization to the European Medicines Agency for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.

1 Jul 2013

First clinical study for development of SGX203 to treat pediatric Crohn's disease

Soligenix, Inc. (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that it has enrolled and treated all patients in the Phase 1 Study BDP-PCD-01; the first clinical study for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the treatment of pediatric Crohn's disease.

1 Jul 2013

Study indicates "statin-intolerant" patients can reduce cholesterol by visiting lipid clinic treatment

Up to 15 percent of patients who take cholesterol-lowering statin medications experience muscle pain or other side effects, and many patients simply stop taking the drugs.

30 Jun 2013

Healthy man injured severely while weight lifting required surgery

A young, healthy man injured himself so severely while weight lifting that he required surgery and nearly a full week in the hospital to recover. The unusual case report of compartment syndrome to the shoulder will be reported online today in Annals of Emergency Medicine ("An Unusual Complication of Weightlifting: A Case Report").

30 Jun 2013

Olfactory ensheathing cells treatment improves neurological function in SCI patients: Study

A team of researchers in Poland who treated three of six paraplegics with spinal cord injury using transplanted olfactory ensheathing cells found that the three treated patients showed neurological improvement and no adverse effects while the three control patients who did not receive transplants saw no improvement.

29 Jun 2013

People receiving emergency gallbladder surgery are more likely to experience complications

If you have severe pain just below the right side of your rib cage, you may have a gallbladder problem. And it is typically better to seek medical attention sooner than later.

28 Jun 2013

New resource guide to tackle prescription drug abuse among youth

To help tackle the serious problem of youth prescription drug abuse, high school teachers will have free access to a new resource guide, Rx for Understanding: Preventing Prescription Drug Abuse.

28 Jun 2013

Janssen receives complete response letter from FDA for XARELTO sNDA

Janssen Research & Development, LLC today announced the U.S. Food and Drug Administration has issued a complete response letter for the supplemental New Drug Application for XARELTO (rivaroxaban) to reduce the risk of stent thrombosis in patients with acute coronary syndrome.

28 Jun 2013

State highlights: Miss. lawmakers ready for special session on Medicaid; Paid sick time approved in NYC; Oregon cuts premium requests

Mississippi lawmakers return to the Capitol at 10 a.m. Thursday for a special session designed to keep Medicaid alive and funded. Much is at stake: Medicaid is a government health insurance program for the needy, and it covers about 644,000 of the state's nearly 3 million residents (6/27).

28 Jun 2013

Pain News and Research

Latest Pain News and Research

ARIAD Pharmaceuticals' Iclusig gets EC marketing authorization for CML and Ph+ ALL treatment

State highlights: Calif. bill to fine firms with workers on Medi-Cal fails; Pa. eyes disallowing apologies used against doctors in court-proceedings

Research roundup: 'Welcome-mat' effect of Medicaid expansion; Setting up shops; California's transition to Medicaid managed care

Osteoarthritis associated genes: an interview with Professor Jonathan Tobias, University of Bristol

Lawmakers gird for new abortion fight as Texas special session convenes

Study shows that PCCs can reverse blood thinning effects of XARELTO in healthy subjects

Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stage breast cancer

Tel-Aviv research shows physicians delay diagnosis of cervical spondylotic myelopathy

DNA fragments in blood may help doctors to quickly identify coronary artery disease

First Edition: July 1, 2013

Pathway Genomics collaborates with Singapore-based company, Parkway Laboratory Services

Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets

First clinical study for development of SGX203 to treat pediatric Crohn's disease

Study indicates "statin-intolerant" patients can reduce cholesterol by visiting lipid clinic treatment

Healthy man injured severely while weight lifting required surgery

Olfactory ensheathing cells treatment improves neurological function in SCI patients: Study

People receiving emergency gallbladder surgery are more likely to experience complications

New resource guide to tackle prescription drug abuse among youth

Janssen receives complete response letter from FDA for XARELTO sNDA

State highlights: Miss. lawmakers ready for special session on Medicaid; Paid sick time approved in NYC; Oregon cuts premium requests

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Pain News and Research

Latest Pain News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Newsletters you may be interested in